# A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis

> **NCT02464020** · PHASE1 · COMPLETED · sponsor: **University of Minnesota** · enrollment: 8 (actual)

## Conditions studied

- Primary Sclerosing Cholangitis
- Inflammatory Bowel Disease

## Interventions

- **DRUG:** Vancomycin

## Key facts

- **NCT ID:** NCT02464020
- **Lead sponsor:** University of Minnesota
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2017-05-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2020-07-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02464020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02464020, "A Pilot Study to Characterize Bile Acid Metabolism and Dysbiosis in Primary Sclerosing Cholangitis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02464020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*